Recently, s-CEA has been targeted in tumor imaging, using recombinant vaccinia CEA (rV-CEA), or for active immunotherapy with recombinant adenovirus 5 (CEA/MUC1/Brachyury)24. Here, CEACAM5 is linked to neoplasm.